The U.S. Food and Drug Administration (FDA) inspects both 503A and 503B compounding pharmacies to assess if procedures, practices, and controls exist for the preparation of products in compliance with FDA requirements. Are you prepared? Join Eagle Analytical Services General Manager and Chief Technical Officer Ross Caputo, Ph.D., for this FREE webinar, which will help you understand the inspection procedure, provide detailed information regarding the areas in which investigators are trained to evaluate, and outline the inspection process and expectations from the FDA. The information is not intended to convey legal advice; its sole use is for educational purposes.
Latest posts by Eagle Analytical (see all)
- Antimicrobial Effectiveness | USP 795 & 797 Revisions - July 18, 2023
- 2023 PDA/FDA Joint Regulatory Conference, 09/18 – 09/20 - July 11, 2023
- APC: Compounders on Capitol Hill, 09/19 – 09/20 - July 11, 2023